-
-
-
-
-
-
-
PTC Therapeutics reports positive results for Huntington's drug votoplam
-
-
-
-
-
-
-
PTC Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 Financial Results
-
-
-
-
-
-
-
PTC Therapeutics Provides Corporate Update and Reports Third Quarter 2025 Financial Results
-
-
-
-
-
-
-
PTC Therapeutics (PTCT) Tops Q2 EPS by 23c, provides guidance
-
-
-
-
-
-
-
PTC Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results
-
-
-
-
-
-
-
PTC Therapeutics to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results
-
-
-
-
-
-
-
PTC Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
-
1,217,894 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

